多能干细胞来源光感受器替代治疗黄斑变性与视网膜色素变性的研究进展
综述总结人多能干细胞(PSC)来源光感受器及视网膜类器官的制备与表征进展,并汇总PSC光感受器替代的动物模型临床前研究;围绕供体光感受器整合认识的最新转折,聚焦阻碍替代的关键障碍与未来策略,展望PSC技术治疗光感受器退行性疾病的应用前景。
要点
- 人多能干细胞可生成视网膜细胞与视网膜组织,3D培养可获得人视网膜类器官。
- 综述汇总PSC来源可移植光感受器的制备与表征进展及动物模型临床前研究。
- 供体光感受器整合认识出现转折,综述聚焦替代的关键障碍与克服策略。
核心结论
- PSC技术为黄斑变性与视网膜色素变性等致盲性视网膜疾病的光感受器替代提供了治疗方向。
- 综述认为供体光感受器整合认识出现近期转折,并据此讨论克服替代障碍的最有前景策略。
研究设计与样本
- 本文为综述,总结PSC来源可移植光感受器的生成与表征进展及动物模型临床前研究。
主要发现
- 过去十年PSC生成视网膜细胞与视网膜组织取得显著进展。
- 3D培养系统可生成人视网膜类器官,显著增加未来临床应用中的人源材料可及性。
临床怎么用
- 为以替代丢失光感受器为目标的视网膜退行性疾病细胞治疗研发提供方向。
- 强调需围绕供体光感受器整合这一核心环节推进临床前研究。
局限性
- 综述指出供体光感受器整合仍是阻碍光感受器替代的最关键障碍之一。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
The human retina fails to regenerate and cell-based therapies offer options for treatment of blinding retinal diseases, such as macular degeneration and retinitis pigmentosa. The last decade has witnessed remarkable advances in generation of retinal cells and retinal tissue from human pluripotent stem cells (PSCs). The development of 3D culture systems allowing generation of human retinal organoids has substantially increased the access to human material for future clinical applications aiming at replacing the lost photoreceptors in retinal degenerative diseases. This review outlines the advances that have been made toward generation and characterization of transplantable photoreceptors from PSCs and summarizes the current status of PSC-based preclinical studies for photoreceptor replacement conducted in animal models. Considering the recent turning point in our understanding of donor photoreceptor integration, this review focuses on the most crucial obstacles that hinder the photoreceptor replacement, discusses the most promising strategies to overcome them in the future, and provides a perspective on the approaching advancement in the application of PSC technology for treatment of photoreceptor degenerative diseases.
引用
- Gagliardi G, Ben M'Barek K, Goureau O, et al. Photoreceptor cell replacement in macular degeneration and retinitis pigmentosa: A pluripotent stem cell-based approach. Prog Retin Eye Res. 2019. PMID: 30885665. doi:10.1016/j.preteyeres.2019.03.001
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。